Skip to main content
. Author manuscript; available in PMC: 2012 Jan 6.
Published in final edited form as: ChemMedChem. 2010 Aug 2;5(8):1259–1271. doi: 10.1002/cmdc.201000157

Figure 1.

Figure 1

Drug discovery workflow for the identification of potential EtCRK2 inhibitors. The workflow consists of 6 steps with different subtasks. Step 4 “Hit Enrichment” and 5 “In vitro Hit Confirmation” was an iterative cycle process and therefore passed multiple times.